Side-by-side financials for BON and RGC. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BON | RGC |
|---|---|---|
| Market cap | - | $10.11 B |
| US-listed rank | - | #936 |
| Revenue (latest FY) | $18.67M | - |
| Net income (latest FY) | -$1.99M | -$3.58M |
| Net margin | -10.7% | - |
| SEC filings | 151 | 82 |
Full pages: Bon Natural Life Ltd and Regencell Bioscience Holdings Ltd, or browse the full rankings.